BRYZOLDIV
Live / Allowed — Published for opposition (as of 27 Oct 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 10 Jul 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99934162
- Mark type
- Word mark
- Filed
- 10 Jul 2026
- Published for opposition
- 27 Oct 2026
- Attorney of record
- Xiomara Triana
Goods and services
- Class 005 — Pharmaceuticals: Antivirals; Antibodies for medical purposes; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes; Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, autoimmune diseases, solid organ transplant rejection, autoinflammatory diseases, blood diseases, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, Alzheimer’s disease, autism spectrum disorder, and musculoskeletal and skin diseases; Biological preparations for the treatment of cancer
Owner
- Juno Therapeutics, Inc., Seattle, WA, US
- Juno Therapeutics, Inc., Seattle, WA, US
Prosecution history
- 27 Oct 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Oct 2026 — PUBLISHED FOR OPPOSITION
- 21 Oct 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Sept 2026 — ASSIGNED TO EXAMINER
- 10 Jul 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 10 Jul 2026 — APPLICATION FILING RECEIPT MAILED
- 10 Jul 2026 — NEW APPLICATION ENTERED